FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TEPROTUMUMAB
异名/同义词HZN001
HZN-001
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (CD221)), HUMAN MONOCLONAL IMC-11F8 .GAMMA.1 HEAVY CHAIN (221-215')-DISULFIDE WITH HUMAN MONOCLONAL IMC-11F8 .KAPPA. LIGHT, DIMER (227-227'':230-230'')-BISDISULFIDE
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
R-1507
RG1507
RG-1507
RO4858696
RO-4858696
RO4858696-000
RO-4858696000
RO-4858696-000
RV001 MONOCLONAL
RV-001 MONOCLONAL
TEPEZZA
TEPROTUMUMAB
TEPROTUMUMAB [INN]
TEPROTUMUMAB [MI]
TEPROTUMUMAB [USAN]
TEPROTUMUMAB [WHO-DD]
TEPROTUMUMAB TRBW [WHO-DD]
TEPROTUMUMAB-TRBW
CAS登记号1036734-93-6
物质唯一标识(Unique Ingredient Identifier)Y64GQ0KC0A
分子式9107
国际化合物标识(International Chemical Identifier,InChI)XX-19
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)289-554-4
成分类型 /
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System